1,030 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
BLS Reports Robust July Jobs: 255K, 4.9% Unemployment http://www.zacks.com/stock/news/227064/bls-reports-robust-july-jobs-255k-49-unemployment?cid=CS-ZC-FT-227064 Aug 05, 2016 - Also, May's paltry 11K jobs was more than doubled to 24K, and even June's strong 287K rose another 5000 jobs to 292K.
Immune Design (IMDZ): Stock to Disappoint on Q2 Earnings? http://www.zacks.com/stock/news/226941/immune-design-imdz-stock-to-disappoint-on-q2-earnings?cid=CS-ZC-FT-226941 Aug 04, 2016 - Immune Design Corp. (IMDZ) is scheduled to report second-quarter 2016 results after the market closes on Aug 9.
Pharma ETFs Soaring on Solid Q2 Earnings http://www.zacks.com/stock/news/226660/pharma-etfs-soaring-on-solid-q2-earnings?cid=CS-ZC-FT-226660 Aug 03, 2016 - Pharma ETFs are in focus in the days ahead on impressive Q2 results.
Biogen (BIIB) Stock Surges 8% on Takeover Rumors http://www.zacks.com/stock/news/226424/biogen-biib-stock-surges-8-on-takeover-rumors?cid=CS-ZC-FT-226424 Aug 02, 2016 - Biogen (BIIB) stock jumped 8% on late-afternoon trading on Tuesday on rumors that the company could be bought out by either Allergan (AGN) or Merck (MRK), both large-cap pharmaceutical companies.
Company News for August 01, 2016 http://www.zacks.com/stock/news/226056/company-news-for-august-01-2016?cid=CS-ZC-FT-226056 Aug 01, 2016 - Companies in the News are: XRX,MRK,ABBV,EXPE
What Awaits MNK & Other Drug Stocks this Earnings Season? http://www.zacks.com/stock/news/226043/what-awaits-mnk-other-drug-stocks-this-earnings-season?cid=CS-ZC-FT-226043 Aug 01, 2016 - Let's see what's in store for some medical companies that are expected to declare quarterly numbers on Aug 2.
Merck & Co. (MRK) Kenneth C. Frazier on Q2 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3993254-merck-and-co-mrk-kenneth-c-frazier-q2-2016-results-earnings-call-transcript?source=feed_sector_healthcare Jul 29, 2016 - Merck & Co., Inc. (NYSE:MRK)Q2 2016 Earnings CallJuly 29, 2016 8:00 am ETExecutivesTeri Loxam - Investor Relations ContactKenneth C. Frazier - Chairman, President & Chief Executive OfficerRobert M. Da
Merck (MRK) Updates Outlook Following Q2 Earnings Beat http://www.zacks.com/stock/news/225848/merck-mrk-updates-outlook-following-q2-earnings-beat?cid=CS-ZC-FT-225848 Jul 29, 2016 - Merck (MRK) surpassed Q2 earnings expectations by a penny while revenues were in-line with estimates.
Agenus (AGEN) Posts Narrower than Expected Loss in Q2 http://www.zacks.com/stock/news/225836/agenus-agen-posts-narrower-than-expected-loss-in-q2?cid=CS-ZC-FT-225836 Jul 29, 2016 - Agenus (AGEN) reported first-quarter 2016 loss of 24 cents per share, narrower than the Zacks Consensus Estimate of a loss of 34 cents.
Merck (MRK) Beats on Q2 Earnings by a Penny http://www.zacks.com/stock/news/225733/merck-mrk-beats-on-q2-earnings-by-a-penny?cid=CS-ZC-FT-225733 Jul 29, 2016 - Merck (MRK), which surpassed Q2 earnings expectations by a penny, updated its outlook for 2016.

Pages: 1...96979899100101102103

<<<Page 101>